NCT03201861View on ClinicalTrials.gov

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

PHASE3RecruitingINTERVENTIONAL
Enrollment

762

Participants

Timeline

Start Date

July 27, 2017

Primary Completion Date

August 31, 2027

Study Completion Date

December 31, 2027

Conditions
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
Interventions
DRUG

Paclitaxel, Cisplatin

weekly paclitaxel and cisplatin

DRUG

EC to docetaxel or paclitaxel

Standard adjuvant chemotherapy recommended by guideline

Trial Locations (1)

200127

RECRUITING

Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER